• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Gastroenterology

Splanchnic vein thrombosis associated with high risk of bleeding and recurrent thrombosis

byAnees DaudandJames Jiang
July 14, 2015
in Gastroenterology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Amongst a multi-center, international cohort of patients diagnosed with splanchnic vein thrombosis (SVT), the risk of recurrent thrombotic events, while lower during the period of time on anticoagulation, was substantial during the discontinuation phase and equally high amongst those who never received any anticoagulation treatment.

2. Patients with SVT in the setting of cirrhosis had the highest risk of bleeding and recurrent thrombotic events, so the risks versus benefits of anticoagulation in this particular cohort remained unclear.

Evidence Rating Level: 2 (Good)

Study Rundown: Splanchnic vein thrombosis (SVT) is a rare, but often troublesome disease. While the mainstay of treatment is anticoagulation, there is little information regarding the prognosis for these patients. This is perhaps complicated by the fact that a relatively heterogeneous set of comorbidities predisposes patients to this disease, rather than one unifying illness. This study was conducted to determine the long-term clinical outcomes in patients with SVT. The results of the study showed that the risk of recurrent thrombotic events, while lower during the period of time on anticoagulation, was substantial during the discontinuation phase and equally high amongst those who never received any anticoagulation treatment. Patients with SVT in the setting of cirrhosis had the highest risk of bleeding and recurrent thrombotic events, so the risks versus benefits of anticoagulation in this particular cohort remained unclear.

The major strength of the study was the inclusion of multiple centers around the world. Additionally, no particular exclusion criteria were used, so the results are applicable to any patient diagnosed with SVT. Weaknesses of the study included the relatively small number of patients in the study, which was difficult to change since the condition is relative rare, as well as significant variations in management amongst the patients.

Click to read the study, published today in JAMA Internal Medicine

Click to read an invited commentary in JAMA Internal Medicine

RELATED REPORTS

SARS-CoV-2 infection during pregnancy associated with severe maternal morbidity, preterm birth, and venous thromboembolism

#VisualAbstract: Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19

Aspirin use was not effective at reducing mortality in patients hospitalized with COVID-19

Relevant Reading: Survival and recurrence in patients with splanchnic vein thromboses

In-Depth [prospective cohort]: This was a multi-center, international prospective cohort study promoted through the International Society on Thrombosis and Hemostasis (ISTH). Inclusion criteria were objectively diagnosed SVT within six months of initiation in the study. There were no exclusion criteria. The study was conducted from 2008 to 2012, with follow up ending in 2014. Major endpoints evaluated were duration of antithrombotic therapy, major bleeding episodes and thrombosis events.

There were 604 patients in the study, of whom 465 received anticoagulation therapy. The mean duration of treatment was 13.9 months, with a standard deviation of 9.2 months. The rate of major bleeding for those on anticoagulation was 3.9 per 100 patient-years (95%CI 2.6-6.0), which reduced to 1.0 per 100 patient-years (95%CI 0.3-4.2) when therapy was discontinued. None of these bleeds were fatal. Amongst patients who never received anticoagulation, the rate of major bleeding was 5.8 per 100 patient-years (95%CI 3.1-10.7). The risk of bleeding was highest amongst patients with liver cirrhosis (10 per 100 patient-years) compared to all other comorbidities. In regards to thrombotic events, for patients on anticoagulation therapy, the rate was 5.6 per 100 patient-years (95%CI 3.9-8.0). This increased to 10.5 per 100 patient-years (95%CI 6.8-16.3) during the discontinuation phase. By comparison, for those who never received anticoagulation, thrombotic rate was 9.2 per 100 patient-years (95%CI 5.7-15.1). Again, the rate of thrombotic events was highest amongst those with liver cirrhosis (11.3 per 100 patient-years).

Image: CC/Wiki

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: venous thromboembolism
Previous Post

2 Minute Medicine Rewind July 6 – July 12, 2015

Next Post

Diet and physical activity promotion associated with decreased risk of type 2 diabetes

RelatedReports

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Hematology

SARS-CoV-2 infection during pregnancy associated with severe maternal morbidity, preterm birth, and venous thromboembolism

March 24, 2022
#VisualAbstract: Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19
StudyGraphics

#VisualAbstract: Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19

January 26, 2022
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Cardiology

Aspirin use was not effective at reducing mortality in patients hospitalized with COVID-19

January 25, 2022
Most anticoagulants for venous thromboembolism similarly effective
Hematology

Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19

January 18, 2022
Next Post
Diet and physical activity promotion associated with decreased risk of type 2 diabetes

Diet and physical activity promotion associated with decreased risk of type 2 diabetes

Institutional review board conflicts of interest persist, but with increased disclosure

Institutional review board conflicts of interest persist, but with increased disclosure

CT and MR imaging measurements reflect symptoms of progressive lung disease

CT and MR imaging measurements reflect symptoms of progressive lung disease

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Treatment of anal high-grade squamous intraepithelial lesions can reduce rates of progression to invasive anal cancer.
  • High tumour mutation burden in NSCLC associated with improved clinical outcomes of PD-L1 blockade across PD-L1 expression subgroups
  • Subsidization of supermarkets may help reduce obesity risk in children
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.